Clinical trial

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

NCT03233191

View saved research
StatusACTIVE_NOT_RECRUITING
Study typeINTERVENTIONAL
Start date2017-09-28
PhasePHASE3

Study timeline

Study start (actual)2017-09-28Date precision: day
Registry last updated2026-09-04
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

What this registered study describes

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer is a interventional study listed under registry identifier NCT03233191. Its last published status is ACTIVE NOT RECRUITING. Registry status does not establish that enrollment is currently open at every study site.

The published record lists 1 condition label(s), 3 intervention label(s), and 3 sponsor/collaborator entry or entries. The structured information below allows these links to be examined individually; intervention registration is not an efficacy claim.

Source: the original ClinicalTrials.gov study record. Always check the protocol, eligibility, dates, results (when posted), and contacts at the original source.

Mapped research locations

PhoenixArizona, United States4New YorkNew York, United States3HoustonTexas, United States3PhiladelphiaPennsylvania, United States3Los AngelesCalifornia, United States2TorontoOntario, Canada2NashvilleTennessee, United States2DetroitMichigan, United States2Ann ArborMichigan, United States2The BronxNew York, United States2New OrleansLouisiana, United States2MemphisTennessee, United States2NorfolkVirginia, United States2SpartanburgSouth Carolina, United States2Baton RougeLouisiana, United States2ShreveportLouisiana, United States2BoiseIdaho, United States2BostonMassachusetts, United States1ChicagoIllinois, United States1DallasTexas, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1ColumbusOhio, United States1MontrealQuebec, Canada1DurhamNorth Carolina, United States1Washington D.C.District of Columbia, United States1IndianapolisIndiana, United States1MinneapolisMinnesota, United States1JacksonvilleFlorida, United States1AuroraColorado, United States1DenverColorado, United States1RochesterNew York, United States1RochesterMinnesota, United States1CharlestonSouth Carolina, United States1Chapel HillNorth Carolina, United States1Winston-SalemNorth Carolina, United States1VancouverBritish Columbia, Canada1Little RockArkansas, United States1AlbuquerqueNew Mexico, United States1MadisonWisconsin, United States1OttawaOntario, Canada1Buenos AiresArgentina1LondonOntario, Canada1ScottsdaleArizona, United States1GreenvilleSouth Carolina, United States1Iowa CityIowa, United States1QuébecQuebec, Canada1CharlottesvilleVirginia, United States1HonoluluHawaii, United States1San JuanPuerto Rico1KnoxvilleTennessee, United States1Colorado SpringsColorado, United States1Grand RapidsMichigan, United States1CantonOhio, United States1New BrunswickNew Jersey, United States1WorcesterMassachusetts, United States1ColumbiaSouth Carolina, United States1FargoNorth Dakota, United States1HersheyPennsylvania, United States1MobileAlabama, United States1Saint PaulMinnesota, United States1SavannahGeorgia, United States1Des MoinesIowa, United States1NewarkDelaware, United States1LimaPeru1KalamazooMichigan, United States1MorgantownWest Virginia, United States1Saint Louis ParkMinnesota, United States1Farmington HillsMichigan, United States1UrbanaIllinois, United States1BakersfieldCalifornia, United States1DuluthMinnesota, United States1DecaturIllinois, United States1

Clinical trial site map

Published registry research cities for this specific study. Pins represent city-level locations, not exact facility addresses. Confirm current enrollment and facility details with the study team.

79 published city locations shown (maximum 300). Some registry locations may not have coordinates or may not be published yet.

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.